HC Wainwright Issues Positive Outlook for Liquidia Earnings

Liquidia Co. (NASDAQ:LQDA - Free Report) - Equities researchers at HC Wainwright lifted their FY2024 earnings per share estimates for shares of Liquidia in a note issued to investors on Thursday, November 14th. HC Wainwright analyst A. Fein now expects that the company will post earnings per share of ($1.51) for the year, up from their previous forecast of ($1.54). HC Wainwright has a "Buy" rating and a $29.00 price target on the stock. The consensus estimate for Liquidia's current full-year earnings is ($1.55) per share. HC Wainwright also issued estimates for Liquidia's FY2025 earnings at ($1.62) EPS and FY2028 earnings at ($0.16) EPS.

Several other equities analysts have also issued reports on the company. Lifesci Capital began coverage on Liquidia in a research report on Thursday, October 3rd. They set an "outperform" rating and a $30.00 price target on the stock. Needham & Company LLC restated a "buy" rating and set a $19.00 price target on shares of Liquidia in a research report on Thursday. BTIG Research cut their price objective on Liquidia from $29.00 to $25.00 and set a "buy" rating on the stock in a research report on Monday, August 19th. Scotiabank initiated coverage on Liquidia in a research report on Wednesday, October 16th. They issued a "sector outperform" rating and a $30.00 price objective on the stock. Finally, Bank of America lowered their target price on Liquidia from $24.00 to $23.00 and set a "buy" rating for the company in a research note on Tuesday, August 20th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, six have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $24.00.

Liquidia Stock Performance

LQDA traded down $0.06 on Monday, hitting $9.78. 16,534 shares of the company were exchanged, compared to its average volume of 976,989. The firm has a fifty day simple moving average of $10.52 and a two-hundred day simple moving average of $11.48. Liquidia has a 12 month low of $6.33 and a 12 month high of $16.99. The stock has a market capitalization of $827.78 million, a PE ratio of -6.04 and a beta of 0.21.

Insider Transactions at Liquidia

In other news, General Counsel Russell Schundler sold 2,576 shares of the business's stock in a transaction on Monday, October 14th. The stock was sold at an average price of $11.11, for a total value of $28,619.36. Following the completion of the transaction, the general counsel now owns 486,048 shares in the company, valued at $5,399,993.28. The trade was a 0.53 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Rajeev Saggar sold 2,526 shares of the business's stock in a transaction on Friday, October 18th. The stock was sold at an average price of $11.19, for a total value of $28,265.94. Following the completion of the transaction, the insider now owns 204,857 shares of the company's stock, valued at $2,292,349.83. This represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 21,551 shares of company stock worth $236,021 over the last quarter. 30.10% of the stock is currently owned by insiders.

Institutional Trading of Liquidia

Several large investors have recently modified their holdings of the company. Barclays PLC grew its holdings in shares of Liquidia by 265.0% in the third quarter. Barclays PLC now owns 99,984 shares of the company's stock worth $999,000 after acquiring an additional 72,591 shares during the period. Anson Funds Management LP bought a new stake in shares of Liquidia in the third quarter worth $1,764,000. XTX Topco Ltd bought a new stake in shares of Liquidia in the third quarter worth $323,000. Wellington Management Group LLP grew its holdings in shares of Liquidia by 12.5% in the third quarter. Wellington Management Group LLP now owns 179,923 shares of the company's stock worth $1,799,000 after acquiring an additional 19,932 shares during the period. Finally, Whitefort Capital Management LP grew its holdings in shares of Liquidia by 119.8% in the third quarter. Whitefort Capital Management LP now owns 1,702,025 shares of the company's stock worth $17,020,000 after acquiring an additional 927,546 shares during the period. Institutional investors own 64.54% of the company's stock.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).